Retina

Ora’s Retina team possesses both the experience and expertise to design, conduct, and consult upon comprehensive development plans for products designed for the treatment of retinal diseases.

We tailor our development work to fit the unique needs of our diverse client base, which ranges from small virtual entities to large pharmaceutical companies. Our flexibility enables us to offer our clients expert guidance on any or all aspects of development, from pre-clinical model design to phase IV studies:

Comprehensive Product Development Programs for retinal indications

• Regulatory expertise
• Scientific advisory boards
• Trial design
• Trial conduct and management (Phases I through IV), including trial staff training
• Medical protocol and report writing
• Formulation development capabilities

Scientific and medical interaction with retinal medical community

• Medical writing, publications and presentations (posters, manuscripts, trade journal articles)
• Brand Identity Development
• Marketing and Advertising materials
• Market research, focus groups and advocacy groups

Pre-Clinical Model Research

• Neuroprotection models

  Ischemia, Optic nerve crush, Optic nerve transaction, Light-induced retinal degeneration

• Dry age-related macular degeneration

  Ora AMD model, Smoking mouse model

• Wet age-related macular degeneration

  Laser induced CNV, VEGF induced CNV

• Hereditary retinal disease

  rd mice, rds mice

• Diabetic retinopathy

  STZ-induced diabetic retinopathy

Clinical Research of Patient Ocular Psychophysical Function in Retinal Diseases

No matter what your current development needs, Ora’s team has the broad experience and expertise to help you reach your development goals.  For more information, please contact Ora's Retina Department directly at retina@oraclinical.com.